Yiftah Beer

Dr. Yiftah Beer

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2015 in Journal of Foot and Ankle Research
Verified
Journal Article
Open access
PDF file
RGRoy Gigi
Roy Gigi
AHAmir Haim
Amir Haim
ELElchanan Luger
Elchanan Luger
GSGanit Segal
Ganit Segal
EMEyal Melamed
Eyal Melamed
AEAvi Elbaz
Avi Elbaz
Background: Gait metric alterations have been previously reported in patients suffering from chronic ankle instability (CAI). Previous studies of gait in this population have been comprised of relatively small cohorts, and the findings of these studies are not uniform. The objective of the present study was to examine spatiotemporal gait metrics in patients with CAI and examine the relationship between self‐reported disease severity and the magnitude of gait abnormalities.Methods: Forty‐four patients with CAI were identified and compared to 53 healthy controls. Patients were evaluated with spatiotemporal gait analysis via a computerized mat and with the Short Form (SF) ‐ 36 health survey.Results: Patients with CAI were found to walk with approximately 16% slower walking velocity, 9% lower cadence and approximately 7% lower step length. Furthermore, the base of support, during walking, in the CAI group was approximately 43% wider, and the single limb support phase was 3.5% shorter compared to the control group.All of the SF‐36 8‐subscales, as well as the SF‐36 physical component summary and SF‐36 mental component summary, were significantly lower in patients with CAI compared to the control group. Finally, significant correlations were found between most of the objective gait measures and the SF‐36 mental component summary and SF‐36 physical component summary.Conclusions: The results outline a gait profile for patients suffering from CAI. Significant differences were found in most spatiotemporal gait metrics. An important finding was a significantly wider base of support. It may be speculated that these gait alterations may reflect a strategy to deal with imbalance and pain. These findings suggest the usefulness of gait metrics, alongside with the use of self‐evaluation questionnaires, in assessing disease severity of patients with CAI.

27 June 2011 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
EDEytan M Debbi
Eytan M Debbi
GAGabriel Agar
Gabriel Agar
GFGil Fichman
Gil Fichman
YZYaron Bar Ziv
Yaron Bar Ziv
RKRami Kardosh
Rami Kardosh
RDRonen Debi
Ronen Debi
Patients with osteoarthritis (OA) take a variety of health supplements in an attempt to reduce pain and improve function. The aim of this study was to determine the efficacy of methylsulfonylmethane (MSM) in treating patients with knee OA.

2 June 2023 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
RGRon Gilat
Ron Gilat
IMIlan Y Mitchnik
Ilan Y Mitchnik
TMTomer Mimouni
Tomer Mimouni
GAGabriel Agar
Gabriel Agar
DLDror Lindner
Dror Lindner
Yiftah BeerYiftah Beer
Yiftah Beer

13 September 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
OPOrit Peled
Orit Peled
YVYael Vitzrabin
Yael Vitzrabin
ENEran Beit Ner
Eran Beit Ner
MLMoran Lazaryan
Moran Lazaryan
MBMaya Berlin
Maya Berlin
ETEran Tamir
Eran Tamir
Introduction: Multidisciplinary expert team collaboration in the clinical setting, which includes clinical pharmacist involvement can facilitate significant improvements in outcomes and optimize patient management by preventing drug-related problems (DRP). This type of collaboration is particularly valuable in patients with multi-morbidity and polypharmacy such as diabetic foot patients. Evidence regarding the successful integration of a new clinical pharmacist, without previous experience into a unit is still scarce. Therefore, this study aimed to describe and evaluate the actual successful integration process of the clinical pharmacist into a diabetic foot unit by measuring the change in recommendation acceptance rate over time.Methods: A prospective, exploratory treatment effectiveness study based on the recommendation acceptance rate of a new clinical pharmacist introduced into the diabetic foot unit was conducted over a 9- month period. The clinical pharmacist identified medical and drug-related problems (DRP) or any discrepancies in the prescribing and administration of medications. Each identified DRP was documented and formulated as a recommendation by the clinical pharmacist. The main outcome measure was the acceptance rate of recommendations over time.Results: A total of 86 patients, of which 67% were men, averagely aged 66.5 (SD 11.8) years were evaluated. Calculated BMI was 30.2 (SD 6.2). The average number of medical diagnoses was 8.9 (SD3.2), and 11.1 (SD 3.7) prescribed drugs for each patient. Cardiovascular disease was presented by 95% (n = 82) of the patients and 33% of them (n = 28) had uncontrolled hyperglycemia. Averagely, 3.3 (SD 1.9) DRPs were identified pre patient. The efficacy-related DRP recommendation acceptance rate increased over the study period from 37.8% in the first 4 months to 79.4% after a period of 4.75 months. Safety-related DRP recommendation acceptance rate increased from 56% to 67.6%.Conclusion: Improved clinical outcomes and optimized pharmacologic patient management may be achieved by the successful integration of a clinical pharmacist into the team. This study provides evidence of the increasing recommendation acceptance rate of integrated, pharmacist-driven comprehensive medication management in an unexperienced unit. To overcome challenges, team members should collaborate to fully integrate the clinical pharmacist into the team-based structure and utilize proper strategies to minimize and transcend barriers.

12 July 2023 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
RGRon Gilat
Ron Gilat
IMIlan Y Mitchnik
Ilan Y Mitchnik
SPSumit Patel
Sumit Patel
JDJeremy Dubin
Jeremy Dubin
GAGabriel Agar
Gabriel Agar
Yiftah BeerYiftah Beer
Yiftah Beer

3 March 2014 in Sports Health: A Multidisciplinary Approach
Verified
Journal Article
Open access
DLDror Lindner
Dror Lindner
GAGabriel Agar
Gabriel Agar
BDBenjamin Gilbert Domb
Benjamin Gilbert Domb
Yiftah BeerYiftah Beer
Yiftah Beer
ISIdit Shub
Idit Shub
GMGideon Mann
Gideon Mann
Cycling has become a popular recreational and competitive sport. The number of people participating in the sport is gradually increasing. Despite being a noncontact, low-impact sport, as many as 85% of athletes engaged in the sport will suffer from an overuse injury, with the lower limbs comprising the majority of these injuries. Up to 20% of all lower extremity overuse injuries in competitive cyclists are of a vascular source. A 39-year-old competitive cyclist had a 5-year history of thigh pain during cycling, preventing him from competing. The patient was eventually diagnosed with external iliac artery endofibrosis. After conservative treatment failed, the patient underwent corrective vascular surgery with complete resolution of his symptoms and return to competitive cycling by 1 year. Since its first description in 1985, there have been more than 60 articles addressing external iliac artery endofibrosis pathology.